Serum levels of soluble urokinase plasminogen activator receptor (suPAR) predict outcome after resection of colorectal liver metastases

Oncotarget | https://doi.org/10.18632/oncotarget.25471 Sven H. Loosen, Frank Tacke, Marcel Binnebosel, Catherine Leyh, Mihael Vucur, Florian Heitkamp, Wenzel Schoening, Tom F. Ulmer, Patrick H. Alizai, Christian...

Bibliographic Details

Main Authors:	Loosen, Sven (Author) , Tacke, Frank (Author) , Binnebosel, Marcel (Author) , Leyh, Catherine (Author) , Vucur, Mihael (Author) , Heitkamp, Florian (Author) , Schoening, Wenzel (Author) , Ulmer, Tom F. (Author) , Alizai, Patrick H. (Author) , Trautwein, Christian (Author) , Koch, Alexander (Author) , Longerich, Thomas (Author) , Roderburg, Christoph (Author) , Neumann, Ulf P. (Author) , Luedde, Tom (Author)
Format:	Article (Journal)
Language:	English
Published:	June 05, 2018
In:	OncoTarget Year: 2018, Volume: 9, Issue: 43, Pages: 27027-27038
ISSN:	1949-2553
DOI:	10.18632/oncotarget.25471
Online Access:	Verlag, Volltext: https://doi.org/10.18632/oncotarget.25471 Verlag, Volltext: http://www.oncotarget.com/index.php?journal=oncotarget&page=article&op=view&path[]=25471&path[]=79759
Author Notes:	Sven H. Loosen, Frank Tacke, Marcel Binnebosel, Catherine Leyh, Mihael Vucur, Florian Heitkamp, Wenzel Schoening, Tom F. Ulmer, Patrick H. Alizai, Christian Trautwein, Alexander Koch, Thomas Longerich, Christoph Roderburg, Ulf P. Neumann and Tom Luedde